These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 25055831

  • 1. Concerns over data in key dabigatran trial.
    Cohen D.
    BMJ; 2014 Jul 23; 349():g4747. PubMed ID: 25055831
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Dabigatran, bleeding, and the regulators.
    Moore TJ, Cohen MR, Mattison DR.
    BMJ; 2014 Jul 23; 349():g4517. PubMed ID: 25056265
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Is there really misuse and abuse of dabigatran?
    Eikelboom JW, Hankey GJ.
    Med J Aust; 2013 Apr 15; 198(7):358-9. PubMed ID: 23581946
    [No Abstract] [Full Text] [Related]

  • 7. Dabigatran monitoring made simple?
    Eikelboom JW, Weitz JI.
    Thromb Haemost; 2013 Sep 15; 110(3):393-5. PubMed ID: 23884303
    [No Abstract] [Full Text] [Related]

  • 8. CHA2DS2-VASc and HAS-BLED scores and activated partial thromboplastin time for prediction of high plasma concentration of dabigatran at trough.
    Owada S, Tomita H, Kinjo T, Ishida Y, Itoh T, Sasaki K, Horiuchi D, Kimura M, Sasaki S, Okumura K.
    Thromb Res; 2015 Jan 15; 135(1):62-7. PubMed ID: 25466835
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Perioperative Management of Dabigatran: A Prospective Cohort Study.
    Schulman S, Carrier M, Lee AY, Shivakumar S, Blostein M, Spencer FA, Solymoss S, Barty R, Wang G, Heddle N, Douketis JD, Periop Dabigatran Study Group.
    Circulation; 2015 Jul 21; 132(3):167-73. PubMed ID: 25966905
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Dabigatran: life-threatening bleeding.
    Prescrire Int; 2013 Feb 21; 22(135):41-3. PubMed ID: 23444501
    [Abstract] [Full Text] [Related]

  • 15. Bleeding events and activated partial thromboplastin time with dabigatran in clinical practice.
    Kawabata M, Yokoyama Y, Sasano T, Hachiya H, Tanaka Y, Yagishita A, Sugiyama K, Nakamura T, Suzuki M, Isobe M, Hirao K.
    J Cardiol; 2013 Aug 21; 62(2):121-6. PubMed ID: 23680005
    [Abstract] [Full Text] [Related]

  • 16. The use, misuse and abuse of dabigatran.
    Attia JR, Pearce R.
    Med J Aust; 2013 Apr 15; 198(7):356-7. PubMed ID: 23581945
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Anticoagulant therapy in connection with cardioversion in patients with atrial fibrillation].
    Furman NV, Kuvshinova LE, Dovgalevskiĭ IaP.
    Kardiologiia; 2012 Apr 15; 52(9):69-76. PubMed ID: 23098549
    [Abstract] [Full Text] [Related]

  • 20. Thrombolysis treatment for acute ischaemic stroke in a patient on treatment with dabigatran.
    Matute MC, Guillán M, García-Caldentey J, Buisan J, Aparicio M, Masjuan J, Alonso de Leciñana M.
    Thromb Haemost; 2011 Jul 15; 106(1):178-9. PubMed ID: 21505718
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.